Table 1.
Characteristics of 626 study patients.
| Demographics/Pre-Procedure Variables
| |
|---|---|
| Age (mean years ± SD) | 56.0 ± 10.4 |
| Body Mass Index (kg/m2 ± SD) | 28.9 ± 5.3 |
|
| |
| n (%) | |
|
| |
| Males | 338 (54.0) |
| Ethnicity | |
| White | 114 (18.2) |
| Black | 373 (59.6) |
| Hispanic | 110 (17.6) |
| Asian | 21 (3.4) |
| Other | 8 (1.3) |
|
| |
| ASA Physical Status Class | |
| I | 84 (13.4) |
| II | 525 (83.9) |
| III | 12 (1.9) |
| IV | 0 (0.0) |
|
| |
| Blood Pressure Medication Class | |
| ≥1 Medication | 158 (25.2) |
| Multiple (≥2 Medications) | 133 (21.2) |
| ACE inhibitor | 78 (12.5) |
| CCB | 69 (11.0) |
| Diuretic | 69 (11.0) |
| BB | 47 (7.5) |
| ARB | 28 (4.5) |
|
| |
| Co-Morbidities | |
| Asthma/COPD | 45 (7.2) |
| Coronary Artery Disease | 12 (1.9) |
| Congestive Heart Failure | 6 (1.0) |
ACE – angiotensin converting enzyme; ARB –angiotensin receptor blocker; ASA - American Society of Anesthesiologists; BB – beta blocker; CCB – calcium channel blocker; COPD – chronic obstructive pulmonary disease; SD – standard deviation